VEGFA and retinopathy of prematurity: The treatment of ROP was mainly laser therapy in 86% (82 out of 95), while an additional second diode laser treatment was required in 14% of children (13 out of 95), including only 5.3% (5 out of 95) with diode laser only, diode laser with anti-VEGF injection in 7.4% (7 out of 95), and diode laser with subsequent vitrectomy in 1.1% [25].